Phreesia, Inc. (0A23.L)
USD 25.52
(2.82%)
USD 25.52
(2.82%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 201.74 Million USD | 35.33% |
| 2023 | 171.64 Million USD | 30.19% |
| 2022 | 131.84 Million USD | 36.92% |
| 2021 | 96.29 Million USD | 20.27% |
| 2020 | 80.06 Million USD | 27.3% |
| 2019 | 62.89 Million USD | 25.62% |
| 2018 | 50.06 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 52.84 Million USD | 8.69% |
| 2024 FY | 201.74 Million USD | 17.54% |
| 2024 Q2 | 55.52 Million USD | 5.07% |
| 2024 Q3 | 60.68 Million USD | 9.28% |
| 2024 Q4 | 54.77 Million USD | -9.73% |
| 2023 Q2 | 40.44 Million USD | 9.86% |
| 2023 FY | 171.64 Million USD | 30.19% |
| 2023 Q4 | 48.62 Million USD | 6.23% |
| 2023 Q3 | 45.77 Million USD | 13.18% |
| 2023 Q1 | 36.81 Million USD | 3.21% |
| 2022 Q1 | 30.03 Million USD | 11.13% |
| 2022 Q2 | 31.32 Million USD | 4.31% |
| 2022 Q3 | 34.82 Million USD | 11.16% |
| 2022 Q4 | 35.66 Million USD | 2.42% |
| 2022 FY | 131.84 Million USD | 36.92% |
| 2021 Q4 | 27.02 Million USD | 10.47% |
| 2021 Q3 | 24.46 Million USD | 6.4% |
| 2021 Q2 | 22.99 Million USD | 5.4% |
| 2021 FY | 96.29 Million USD | 20.27% |
| 2021 Q1 | 21.81 Million USD | 0.79% |
| 2020 Q1 | 17.36 Million USD | 5.71% |
| 2020 FY | 80.06 Million USD | 27.3% |
| 2020 Q3 | 21.55 Million USD | 10.5% |
| 2020 Q4 | 21.64 Million USD | 0.41% |
| 2020 Q2 | 19.5 Million USD | 12.33% |
| 2019 Q2 | 15.84 Million USD | 5.25% |
| 2019 Q1 | 15.05 Million USD | 0.0% |
| 2019 Q3 | 15.55 Million USD | -1.83% |
| 2019 FY | 62.89 Million USD | 25.62% |
| 2019 Q4 | 16.42 Million USD | 5.58% |
| 2018 FY | 50.06 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accuray Incorporated | 143.12 Million USD | -40.961% |
| Align Technology, Inc. | 2.72 Billion USD | 92.583% |
| Elevance Health Inc. | 47.01 Billion USD | 99.571% |
| AxoGen, Inc. | 127.87 Million USD | -57.769% |
| Boston Scientific Corporation | 9.84 Billion USD | 97.952% |
| CVS Health Corporation | 54.43 Billion USD | 99.629% |
| Cardinal Health, Inc. | 7.41 Billion USD | 97.279% |
| Centene Corporation | 153.99 Billion USD | 99.869% |
| DaVita Inc. | 3.82 Billion USD | 94.719% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 99.634% |
| Hologic, Inc. | 2.23 Billion USD | 90.985% |
| Humana Inc. | 106.44 Billion USD | 99.81% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 90.788% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | 94.004% |
| Masimo Corporation | 1 Billion USD | 79.896% |
| McKesson Corporation | 12.58 Billion USD | 98.397% |
| Patterson Companies, Inc. | 1.38 Billion USD | 85.383% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | 93.187% |
| ResMed Inc. | 2.6 Billion USD | 92.267% |
| Henry Schein, Inc. | 3.65 Billion USD | 94.474% |
| Teladoc Health, Inc. | 1.84 Billion USD | 89.05% |
| Universal Health Services, Inc. | 1.17 Billion USD | 82.836% |
| Veeva Systems Inc. | 1.68 Billion USD | 88.037% |
| Baxter International Inc. | 4.97 Billion USD | 95.945% |
| Becton, Dickinson and Company | 8.82 Billion USD | 97.713% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 95.734% |
| Danaher Corporation | 14.12 Billion USD | 98.572% |
| Stryker Corporation | 13.05 Billion USD | 98.455% |
| Medtronic plc | 21.27 Billion USD | 99.052% |